Drupal.behaviors.print = function(context) {window.print();window.close();}>
Goldman Sachs Downgrades Life Tech, Affymetrix; Upgrades Myriad, Qiagen
July 02, 2012
Goldman Sachs Downgrades Life Tech, Affymetrix; Upgrades Myriad, Qiagen
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Funding Optimism Grows Among Genomics Researchers, Mizuho Survey Finds
July 30, 2012 / GenomeWeb Daily News
Despite Better Q2 Trends, Tight-fisted Spending Expected for Remainder of 2012, Goldman Sachs Survey Says
July 11, 2012 / GenomeWeb Daily News
Goldman Sachs Revises Estimates for Life Science Tools Firms
April 13, 2012 / GenomeWeb Daily News
Funding Worries Ease Somewhat Among Genomics Researchers, Survey Finds
January 18, 2012 / GenomeWeb Daily News
Goldman Sachs Initiates Coverage of Four MDx Firms
February 23, 2011 / GenomeWeb Daily News